Current report filing


Nov. 15, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 15, 2023
Entity File Number 001-40536
Entity Registrant Name Acurx Pharmaceuticals, Inc.
Entity Central Index Key 0001736243
Entity Tax Identification Number 82-3733567
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 259 Liberty Avenue
Entity Address, City or Town Staten Island
Entity Address, State or Province NY
Entity Address, Postal Zip Code 10305
City Area Code 917
Local Phone Number 533-1469
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol ACXP
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false